MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Accounting Policy > Pharmaceuticals > Accounting Policy followed by Astec Lifesciences - BSE: 533138, NSE: ASTEC
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > ACCOUNTING POLICY - Astec Lifesciences
Astec Lifesciences
BSE: 533138|NSE: ASTEC|ISIN: INE563J01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 22, 17:00
24.15
0.2 (0.84%)
VOLUME 1,992
LIVE
NSE
May 22, 17:00
23.70
-0.3 (-1.25%)
VOLUME 748
« Mar 10
Accounting Policy Year : Mar '11
1.  Basis of preparation of Financial statement
 
 (a) The Financial statement has been prepared under the historical cost
 convention in accordance with the generally accepted accounting
 principles and applicable mandatory. Accounting Standards issued by the
 Institute of Chartered Accountants of India.
 
 (b) The company generally follows mercantile system of accounting and
 recognizes significant items of i ncome and expenditure on accrual
 basis.
 
 2.  Fixed Assets & Capital Work-in-Progress
 
 (a) Fixed Assets are accounted at cost of acquisition or construction
 less depreciation. The company capitalized all direct and indirect
 costs relating to the acquisition and installation of fixed assets, i
 nterest on borrowed funds, if any used to finance acquisition /
 construction of fixed assets are ready for commercial use.
 
 (b) Capital Work-in-Progress comprises outstanding advances paid to
 acquire Fixed Assets and cost of Fixed Assets that are not yet i nstal
 led.
 
 3.  Depreciation and Amortization
 
 a) Depreciation has been provided on straight-line method at the rates
 and in the manner specified in schedule XlVto the companies Act, 1956.
 Depreciation is provided on pro-rata to the period of use.
 
 b) Leasehold land is amortized over the period of lease.
 
 4.  Sales
 
 Revenue from sale of products includes sale value of goods and excise
 duty collected thereon, but excludes sales tax.
 
 Sales turnover are stated at net of trade discount and rebates granted
 during the ordinary course of business.
 
 5.  Inventories
 
 The inventories are valued at lower of cost and net realizable value.
 The basis of determining cost of various categories of inventories are
 as fo I lows:
 
 i.  Raw Materials and Stores : At cost
 
 ii.  Finished Goods : At cost or market value, whichever is lower.
 
 iii.  Work-in-Progress : Atcostor net releasable value, whichever is
 lower. Cost includes
 
 material cost, proportionate share of labour & other man ufacturi ng
 overheads.
 
 6.  Miscel I aneous Expend itu re
 
 Deferred revenue expenditure is being written off over a period of five
 years.
 
 7.  Investments
 
 Long Term Investments are carried at cost of acquisition. Current
 Investment are stated at lower of cost and fair market value.
 
 8.  Impairment of Fixed Assets
 
 At each Balance Sheet date, the company reviews the carrying value of
 tangible and intangible assets for any possible impairment. An
 impairment loss is recognized when the carrying amount of an asset
 exceeds its recoverable amount. The recoverable amount is higher of the
 asset''s net selling price or estimated future cash flows, which are
 discounted to their present value based on appropriate discount rates.
 During the year no provision for impairment of fixed assets has been
 made.
 
 
 9.  Excise Duty and Customs Duty
 
 Excise duty/Customs duty has been accounted on the basis of payments
 made in respect of goods Cleared. Cenvat credit on raw materials and
 capital goods has been accounted for, by reducing the purchase cost of
 raw materials and capital goods respectively.
 
 10.  Segment Reporting
 
 In accordance with the requirement of Accounting Standard -17, Segment
 Reporting issued by the Institute of Chartered Accountants of India,
 the Company''s Business Segment is Manufacturing of Agrochemicals and
 Pharma Intermediates and hence it has no other reportable segment.
 
 Thus the segment wise revenue, Segment wise result, total carrying
 amount of Segment wise assets and Segment wise liability, total cost
 incurred to acquire Segment wise assets, total amount of charge for
 deprecation during the year, isas reflected inthe Financial Statement
 as of and for the year ended March 31,2011.
 
 11.  Foreign Currency Transaction
 
 Foreign currency transactions are recorded at the rates of exchange
 prevailing on the date of the transaction. Exchange differences, if
 any, arising out of transactions settled during the year are recognized
 in the profit & loss account.
 
 Monetary assets and liabilities denominated in foreign currencies as at
 the balance sheet date are translated at the closing exchange rate on
 that date. The exchange differences, if any, are recognized in the
 profit and loss account and related assets and liabilities are
 accordingly restated in the balance sheet.
 
Source : Dion Global Solutions Limited
Quick Links for asteclifesciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.